BASAGLAR 100IU INJECTION
INSULIN
Manufacturer : CIPLA LTDOrigin of Medicine : United States of AmericaIntroduction:
Basaglar 100IU/ml Injection contains insulin glargine. It is used to treat type 1 and type 2 diabetes mellitus in adults and children aged two years and above. Diabetes mellitus is a disorder in which your body does not produce enough insulin or cells don’t respond normally to insulin resulting in high levels of sugar in the blood. Insulin facilitates the entry of glucose to all cells of the body.
Talk to your physician if you have kidney disorders, liver disorders, or heart problems before taking Basaglar 100IU/ml Injection. Your insulin dose may need to be modified during pregnancy, and after giving birth, so talk to your physician if you are pregnant or breastfeeding before taking this medication.
Avoid drinking alcohol while being treated with Basaglar 100IU/ml Injection. You need to inform your physician about all the medications you are taking recently, including herbal medications and supplements as certain medicines may significantly alter blood sugar levels.
Uses of Basaglar 100IU/ml Injection:
- Diabetes mellitus
How Basaglar 100IU/ml Injection works:
Basaglar 100IU/ml Injection lowers blood sugar levels by stimulating glucose uptake especially by fat and skeletal muscle, and by inhibiting hepatic glucose production.
Interactions with other drugs:
Inform your doctor about any medications you are taking or have taken before the treatment.
More information:
- Keep Basaglar 100IU/ml Injection out of sight and reach of children.
- Store in a refrigerator at 2°C - 8°C.
References:
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia,12th edition, 2011, 1250-1252.
- KD Tripathi, Essentials of Medical Pharmacology, Insulin, oral hypoglycaemic drugs and glucagon, 7th edition, 2013, 259-270.
- Sanofi, Electronic medicines compendium (emc), [ Revised on June 2021] [ Accessed on 9th August 2021], https://www.medicines.org.uk/emc/files/pil.2376.pdf
- Eli Lilly and Company, US Food and Drug Administration, [ Revised on July 2021] [ Accessed on 9th August 2021], http://pi.lilly.com/us/basaglar-us-ppi.pdf
How to use Basaglar 100IU/ml Injection:
Always use Basaglar 100IU/ml Injection exactly as your physician tells you to. Read the detailed instructions for use that come with this medication consult your physician if you have any doubts.
Safety advice:
Pregnancy:
Talk to your physician if you are pregnant or planning to get pregnant before taking Basaglar 100IU/ml Injection. It will be given to you if clearly needed.
Breastfeeding:
Talk to your physician if you are breastfeeding before taking Basaglar 100IU/ml Injection. It will be given to you if clearly needed.
Liver:
You need to tell your doctor if you have any other liver diseases before taking Basaglar 100IU/ml Injection as this medicine should be used with caution in liver disease patients.
Kidney:
You need to tell your doctor if you have any other kidney diseases before taking Basaglar 100IU/ml Injection as this medicine should be used with caution in kidney disease patients.
Driving:
Do not drive or handle any tools or machines unless your doctor says you are ready to engage in such activities.
Others:
- Inform your physician if you have any heart problems before taking Basaglar 100IU/ml Injection.
- Avoid drinking alcohol while being treated with this medication.
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Low blood sugar
Common:
- Weight gain
- Allergic reactions
- Skin thickening or pits at the injection site
- Swelling

Want to know more?
Read Our Editorial Policy
4000+ products
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment
100% secure and trusted payment protection

Easy Return
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.